Determination of beta-defensin genomic copy number in different populations: A comparison of three methods

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Fode, Peder ^a   Jespersgaard, Cathrine ^a   Hardwick, Robert J ^b   Bogle, Helen ^b,f   Theisen, Michael ^a   Dodoo, Daniel ^c   Lenicek, Martin ^d   Vitek, Libor ^d   Vieira, Ana ^e   Freitas, Joao ^e   Andersen, Paal Skytt ^a   Hollox, Edward J ^b  

^a STATENS SERUM INSTITUT   (Denmark)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c University of Ghana   (Ghana)

^d CHARLES UNIVERSITY   (Czech Republic)

^e HOSPITAL GARCIA DE ORTA   (Portugal)

^f NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN; DNA;

ACCURACY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CZECH REPUBLIC; DENMARK; DISEASE ASSOCIATION; DNA TEMPLATE; GENE DOSAGE; GHANA; HUMAN; HUMAN CELL; NORMAL HUMAN; NUCLEIC ACID ANALYSIS; PARALOGUE RATIO TEST; PORTUGAL; PYROSEQUENCING BASED PARALOGUE RATIO TEST; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; UNITED KINGDOM; CHROMOSOME MAP; COHORT ANALYSIS; GENETIC PREDISPOSITION; GENETICS; HUMAN GENOME; METHODOLOGY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; POPULATION; POPULATION GENETICS;

BASE SEQUENCE; BETA-DEFENSINS; CHROMOSOME MAPPING; COHORT STUDIES; CZECH REPUBLIC; DENMARK; GENE DOSAGE; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; GENOME, HUMAN; GHANA; GREAT BRITAIN; HUMANS; MOLECULAR SEQUENCE DATA; POPULATION; PORTUGAL;

EID: 79952048505     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016768     Document Type: Article

References (55)

1. Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, et al. (2006) Global variation in copy number in the human genome. Nature 444: 444-454.
2. Carter NP, (2007) Methods and strategies for analyzing copy number variation using DNA microarrays. Nat Genet 39: S16-S21.
3. Pinto D, Marshall C, Feuk L, Scherer SW, (2007) Copy-number variation in control population cohorts. Hum Mol Genet 16 Spec No. 2: R168-R173.
4. Conrad DF, Pinto D, Redon R, Feuk L, Gokcumen O, et al. (2010) Origins and functional impact of copy number variation in the human genome. Nature 464: 704-712.
5. Kidd JM, Cooper GM, Donahue WF, Hayden HS, Sampas N, et al. (2008) Mapping and sequencing of structural variation from eight human genomes. Nature 453: 56-64.
6. Korbel JO, Urban AE, Affourtit JP, Godwin B, Grubert F, et al. (2007) Paired-end mapping reveals extensive structural variation in the human genome. Science 318: 420-426.
7. Sebat J, Lakshmi B, Troge J, Alexander J, Young J, et al. (2004) Large-scale copy number polymorphism in the human genome. Science 305: 525-528.
8. Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK, et al. (2004) Detection of large-scale variation in the human genome. Nat Genet 36: 949-951.
9. Altshuler D, Daly MJ, Lander ES, (2008) Genetic mapping in human disease. Science 322: 881-888.
10. Hollox EJ, Huffmeier U, Zeeuwen PL, Palla R, Lascorz J, et al. (2008) Psoriasis is associated with increased beta-defensin genomic copy number. Nat Genet 40: 23-25.
11. de Cid R, Riveira-Munoz E, Zeeuwen PL, Robarge J, Liao W, et al. (2009) Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis. Nat Genet 41: 211-215.
12. Huffmeier U, Bergboer JGM, Becker T, Armour JA, Traupe H, et al. (2010) Replication of LCE3C-LCE3B CNV as a Risk Factor for Psoriasis and Analysis of Interaction with Other Genetic Risk Factors. J Invest Dermatol 130: 979-984.
13. Abrahams BS, Geschwind DH, (2008) Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet 9: 341-355.
14. Huse K, Taudien S, Groth M, Rosenstiel P, Szafranski K, et al. (2008) Genetic variants of the copy number polymorphic beta-defensin locus are associated with sporadic prostate cancer. Tumour Biol 29: 83-92.
15. Stefansson H, Rujescu D, Cichon S, Pietiläinen OP, Ingason A, et al. (2008) Large recurrent microdeletions associated with schizophrenia. Nature 455: 232-236.
16. Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, et al. (2008) Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320: 539-543.
17. Xu B, Roos JL, Levy S, van Rensburg EJ, Gogos JA, et al. (2008) Strong association of de novo copy number mutations with sporadic schizophrenia. Nat Genet 40: 880-885.
18. Aitman TJ, Dong R, Vyse TJ, Norsworthy PJ, Johnson MD, et al. (2006) Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature 439: 851-855.
19. Fanciulli M, Norsworthy PJ, Petretto E, Dong R, Harper L, et al. (2007) FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat Genet 39: 721-723.
20. Yang Y, Chung EK, Wu YL, Savelli SL, Nagaraja HN, et al. (2007) Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans. Am J Hum Genet 80: 1037-1054.
21. Heinzen EL, Need AC, Hayden KM, Chiba-Falek O, Roses AD, et al. (2010) Genome-wide scan of copy number variation in late-onset Alzheimer's disease. J Alzheimers Dis 19: 69-77.
22. Weterman MA, van Ruissen F, de Wissel M, Bordewijk L, Samijn JP, et al. (2010) Copy number variation upstream of PMP22 in Charcot-Marie-Tooth disease. Eur J Hum Genet 18: 421-428.
23. Zhang F, Seeman P, Liu P, Gonzaga-Jauregui C, Towne CF, et al. (2010) Mechanisms for Nonrecurrent Genomic Rearrangements Associated with CMT1A or HNPP: Rare CNVs as a Cause for Missing Heritability. The American Journal of Human Genetics 86: 892-903.
24. Thomas B, Beal MF, (2007) Parkinson's disease. Human Molecular Genetics 16: R183-R194.
25. Schaschl H, Aitman TJ, Vyse TJ, (2009) Copy number variation in the human genome and its implication in autoimmunity. Clin Exp Immunol 156: 12-16.
26. Aldred PM, Hollox EJ, Armour JA, (2005) Copy number polymorphism and expression level variation of the human alpha-defensin genes DEFA1 and DEFA3. Hum Mol Genet 14: 2045-2052.
27. Linzmeier R, Ho CH, Hoang BV, Ganz T, (1999) A 450-kb contig of defensin genes on human chromosome 8p23. Gene 233: 205-211.
28. Hollox EJ, Armour JA, Barber JC, (2003) Extensive normal copy number variation of a beta-defensin antimicrobial-gene cluster. Am J Hum Genet 73: 591-600.
29. Ganz T, (2003) Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 3: 710-720.
30. Chertov O, Michiel DF, Xu L, Wang JM, Tani K, et al. (1996) Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J Biol Chem 271: 2935-2940.
31. Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, et al. (1999) Beta-Defensins: Linking Innate and Adaptive Immunity Through Dendritic and T Cell CCR6. Science 286: 525-528.
32. Lai Y, Gallo RL, (2009) AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol 30: 131-141.
33. Niyonsaba F, Ushio H, Nagaoka I, Okamura K, Ogawa H, (2005) The human beta-defensins (-1,-2,-3,-4) and cathelicidin LL-37 induce IL-18 secretion through p38 and ERK MAPK activation in primary human keratinocytes. J Immunol 175: 1776-1784.
34. Boniotto M, Jordan WJ, Eskdale J, Tossi A, Antcheva N, et al. (2006) Human beta-defensin 2 induces a vigorous cytokine response in peripheral blood mononuclear cells. Antimicrob Agents Chemother 206 50: 1433-1441.
35. Jin G, Kawsar HI, Hirsch SA, Zeng C, Jia X, et al. (2010) An antimicrobial peptide regulates tumor-associated macrophage trafficking via the chemokine receptor CCR2, a model for tumorigenesis. PLoS One 5: e10993-.
36. Candille SI, Kaelin CB, Cattanach BM, Yu B, Thompson DA, et al. (2007) A β-defensin mutation causes black coat color in domestic dogs. Science 318: 1418-1423.
37. Semple F, Webb S, Li HN, Patel HB, Perretti M, et al. (2010) Human beta-defensin 3 has immunosuppressive activity in vitro and in vivo. Eur J Immunol 40: 1073-1078.
38. Hollox EJ, Davies J, Griesenbach U, Burgess J, Alton EW, et al. (2005) Beta-defensin genomic copy number is not a modifier locus for cystic fibrosis. J Negat Results Biomed 4: 9-.
39. Hollox EJ, (2008) Copy number variation of beta-defensins and relevance to disease. Cytogenet Genome Res 123: 148-155.
40. Linzmeier RM, Ganz T, (2005) Human defensin gene copy number polymorphisms: comprehensive analysis of independent variation in alpha- and beta-defensin regions at 8p22-p23. Genomics 86: 423-430.
41. Hollox EJ, Barber JC, Brookes AJ, Barber JC, (2008) Defensins and the dynamic genome: What we can learn from structural variation at human chromosome band 8p23.1. Genome Res 18: 1686-1697.
42. Groth M, Szafranski K, Taudien S, Huse K, Mueller O, et al. (2008) High-resolution mapping of the 8p23.1 beta-defensin cluster reveals strictly concordant copy number variation of all genes. Hum Mutat 29: 1247-1254.
43. Bentley RW, Pearson J, Gearry RB, Barclay ML, McKinney C, et al. (2009) Association of Higher DEFB4 Genomic Copy Number With Crohn's Disease. Am J Gastroenterol 105: 354-359.
44. Fellermann K, Stange DE, Schaeffeler E, Schmazl H, Wehkamp J, et al. (2006) A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am J Hum Genet 79: 439-448.
45. Cukier HN, Pericak-Vance MA, Gilbert JR, Hedges DJ, (2009) Sample degradation leads to false-positive copy number variation calls in multiplex real-time polymerase chain reaction assays. Anal Biochem 386: 288-290.
46. Field SF, Howson JM, Maier LM, Walker S, Walker NM, et al. (2009) Experimental aspects of copy number variant assays at CCL3L1. Nat Med 15: 1115-1117.
47. Hollox EJ, (2010) Beta-defensins and Crohn's disease: confusion from counting copies. Am J Gastroenterol 105: 360-362.
48. Stranger BE, Forrest MS, Dunning M, Ingle CE, Beazley C, et al. (2007) Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 315: 848-853.
49. Groth M, Wiegand C, Szafranski K, Huse K, Kramer M, et al. (2010) Both copy number and sequence variations affect expression of human DEFB4. Genes Immun pp. 1158-466.
50. Armour JA, Palla R, Zeeuwen PL, den Heijer M, Schalkwijk J, et al. (2007) Accurate, high-throughput typing of copy number variation using paralogue ratios from dispersed repeats. Nucleic Acids Res 35: e19.
51. Ronaghi M, Karamohamed S, Pettersson B, Uhlén M, Nyrén P, (1996) Real-time DNA sequencing using detection of pyrophosphate release. Anal Biochem 242: 84-89.
52. Bakar SA, Hollox EJ, Armour JAL, (2009) Allelic recombination between distinct genomic locations generates copy number diversity in human β-defensins. Proceedings of the National Academy of Sciences 106: 853-858.
53. Aldous MC, Abu Bakar S, Prescott NJ, Palla R, Soo K, et al. (2010) Measurement methods and accuracy in copy number variation: failure to replicate association of low beta-defensin copy number with colonic Crohn's disease. Hum Mol Genet 19: 4930-4938.
54. Hollox EJ, Detering JC, Dehnugara T, (2009) An integrated approach for measuring copy number variation at the FCGR3 (CD16) locus. Hum Mutat 30: 477-484.
55. Perne A, Zhang X, Lehmann L, Groth M, Stuber F, et al. (2009) Comparison of multiplex ligation-dependent probe amplification and real-time PCR accuracy for gene copy number quantification using the beta-defensin locus. Biotechniques 47: 1023-1028.